192 related articles for article (PubMed ID: 32187575)
21. Correlation between urinary fractionated metanephrines in 24-hour and spot urine samples for evaluating the therapeutic effect of metyrosine: a subanalysis of a multicenter, open-label phase I/II study.
Takekoshi K; Satoh F; Tanabe A; Okamoto T; Ichihara A; Tsuiki M; Katabami T; Nomura M; Tanaka T; Matsuda T; Imai T; Yamada M; Asada S; Kawata N; Naruse M
Endocr J; 2019 Dec; 66(12):1063-1072. PubMed ID: 31511435
[TBL] [Abstract][Full Text] [Related]
22. Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma.
Ahn J; Park JY; Kim G; Jin SM; Hur KY; Lee SY; Kim JH
Endocrinol Metab (Seoul); 2021 Jun; 36(3):697-701. PubMed ID: 34107605
[TBL] [Abstract][Full Text] [Related]
23. [Significance of 3-methoxytyramine urine measurement in the diagnosis of pheochromocytomas and paragangliomas: about 28 patients].
Le Jacques A; Abalain JH; Le Saos F; Carré JL
Ann Biol Clin (Paris); 2011; 69(5):555-9. PubMed ID: 22008135
[TBL] [Abstract][Full Text] [Related]
24. Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine.
Eisenhofer G; Peitzsch M; Kaden D; Langton K; Mangelis A; Pamporaki C; Masjkur J; Geroula A; Kurlbaum M; Deutschbein T; Beuschlein F; Prejbisz A; Bornstein SR; Lenders JWM
Clin Chim Acta; 2019 Mar; 490():46-54. PubMed ID: 30571948
[TBL] [Abstract][Full Text] [Related]
25. Detection of spot urinary free metanephrines and 3-methoxytyramine with internal reference correction for the diagnosis of pheochromocytomas and paragangliomas.
Wang H; Zhang X; Zhen Q; Zou W; Chen H; Luo C; Ding M
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1156():122306. PubMed ID: 32829134
[TBL] [Abstract][Full Text] [Related]
26. Verifying Clinically Derived Reference Intervals for Daily Excretion Rates of Fractionated Metanephrines Using Modern Indirect Reference Interval Models.
Doyle K; Frank EL
Am J Clin Pathol; 2021 Sep; 156(4):691-699. PubMed ID: 33880513
[TBL] [Abstract][Full Text] [Related]
27. Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma.
Wang K; Gao X; Zhang W; Sun N; Xie L; Cong H; Guo Y; Shi X; Zhou Z
Scand J Clin Lab Invest; 2021 Nov; 81(7):564-572. PubMed ID: 34570657
[TBL] [Abstract][Full Text] [Related]
28. A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines.
Sawka AM; Jaeschke R; Singh RJ; Young WF
J Clin Endocrinol Metab; 2003 Feb; 88(2):553-8. PubMed ID: 12574179
[TBL] [Abstract][Full Text] [Related]
29. A simple and rapid analytical method based on solid-phase extraction and liquid chromatography-tandem mass spectrometry for the simultaneous determination of free catecholamines and metanephrines in urine and its application to routine clinical analysis.
Woo HI; Yang JS; Oh HJ; Cho YY; Kim JH; Park HD; Lee SY
Clin Biochem; 2016 May; 49(7-8):573-9. PubMed ID: 26779993
[TBL] [Abstract][Full Text] [Related]
30. Plasma metanephrines in the diagnosis of pheochromocytoma.
Lenders JW; Keiser HR; Goldstein DS; Willemsen JJ; Friberg P; Jacobs MC; Kloppenborg PW; Thien T; Eisenhofer G
Ann Intern Med; 1995 Jul; 123(2):101-9. PubMed ID: 7778821
[TBL] [Abstract][Full Text] [Related]
31. Association Between Urinary Catecholamine Excretion and Urine Volume.
Haap M; Blaschka F; Lehmann R; Hoyer A; Müssig K
Horm Metab Res; 2019 Aug; 51(8):531-538. PubMed ID: 31174227
[TBL] [Abstract][Full Text] [Related]
32. Addition of 3-methoxytyramine or chromogranin A to plasma free metanephrines as the initial test for pheochromocytoma and paraganglioma: Which is the best diagnostic strategy.
Liu L; Xie W; Song Z; Wang T; Li X; Gao Y; Li Y; Zhang J; Guo X
Clin Endocrinol (Oxf); 2022 Feb; 96(2):132-138. PubMed ID: 34486152
[TBL] [Abstract][Full Text] [Related]
33. Analysis of plasma 3-methoxytyramine, normetanephrine and metanephrine by ultraperformance liquid chromatography-tandem mass spectrometry: utility for diagnosis of dopamine-producing metastatic phaeochromocytoma.
Peitzsch M; Prejbisz A; Kroiß M; Beuschlein F; Arlt W; Januszewicz A; Siegert G; Eisenhofer G
Ann Clin Biochem; 2013 Mar; 50(Pt 2):147-55. PubMed ID: 23512172
[TBL] [Abstract][Full Text] [Related]
34. Biochemical Diagnosis of Catecholamine-Producing Tumors of Childhood: Neuroblastoma, Pheochromocytoma and Paraganglioma.
Eisenhofer G; Peitzsch M; Bechmann N; Huebner A
Front Endocrinol (Lausanne); 2022; 13():901760. PubMed ID: 35957826
[TBL] [Abstract][Full Text] [Related]
35. Diagnosing phaeochromocytoma/paraganglioma in a patient presenting with critical illness: biochemistry versus imaging.
Amar L; Eisenhofer G
Clin Endocrinol (Oxf); 2015 Sep; 83(3):298-302. PubMed ID: 25683095
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of urinary metanephrines for the diagnosis of pheochromocytoma].
Bachali Belhadj A; Cherif Miladi E; Bahri S; Chaabane A; Lamouchi H; Khiari K; Khalfallah N; Ben Ammar S
Tunis Med; 2013 Dec; 91(12):724-8. PubMed ID: 24458676
[TBL] [Abstract][Full Text] [Related]
37. Screening for phaeochromocytoma and paraganglioma: impact of using supine reference intervals for plasma metanephrines with samples collected from fasted/seated patients.
Casey R; Griffin TP; Wall D; Dennedy MC; Bell M; O'Shea PM
Ann Clin Biochem; 2017 Jan; 54(1):170-173. PubMed ID: 27166307
[TBL] [Abstract][Full Text] [Related]
38. False-positive results for pheochromocytoma associated with norepinephrine reuptake blockade.
Schürfeld R; Pamporaki C; Peitzsch M; Rayes N; Sabri O; Rohm S; Biemann R; Sandner B; Tönjes A; Eisenhofer G
Endocr Relat Cancer; 2024 Jan; 31(1):. PubMed ID: 37955319
[TBL] [Abstract][Full Text] [Related]
39. Biochemical Assessment of Pheochromocytoma and Paraganglioma.
Eisenhofer G; Pamporaki C; Lenders JWM
Endocr Rev; 2023 Sep; 44(5):862-909. PubMed ID: 36996131
[TBL] [Abstract][Full Text] [Related]
40. Pheochromocytoma catecholamine phenotypes and prediction of tumor size and location by use of plasma free metanephrines.
Eisenhofer G; Lenders JW; Goldstein DS; Mannelli M; Csako G; Walther MM; Brouwers FM; Pacak K
Clin Chem; 2005 Apr; 51(4):735-44. PubMed ID: 15718487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
